Type II-Activated Murine Macrophages Produce IL-4

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  la Flamme, Anne Camille ^a,b   Kharkrang, Marie ^a   Stone, Sarrabeth ^a   Mirmoeini, Sara ^a   Chuluundorj, Delgertsetseg ^a   Kyle, Ryan ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 3; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DERIVATIZATION; FEMALE; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN;

ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-10; INTERLEUKIN-3; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; RECEPTORS, CELL SURFACE;

MURINAE; MUS;

EID: 84867159157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046989     Document Type: Article

References (22)

1. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
2. Dobrovolskaia MA, Vogel SN, (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4: 903-914.
3. Tierney JB, Kharkrang M, La Flamme AC, (2009) Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis. Immunol Cell Biol. 87: 235-40.
4. Ding AH, Nathan CF, Stuehr DJ, (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412.
5. Sutterwala FS, Noel GJ, Salgame P, Mosser DM, (1998) Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med. 188: 217-222.
6. Edwards JP, Zhang X, Frauwirth KA, Mosser DM, (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80: 1298-1307.
7. Anderson CF, Mosser DM, (2002) Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol 168: 3697-3701.
8. La Flamme AC, Harvie M, McNeill A, Goldsack L, Tierney JB, et al. (2006) Fcgamma receptor-ligating complexes improve the course of experimental autoimmune encephalomyelitis by enhancing basal Th2 responses. Immunol Cell Biol 84: 522-529.
9. Mukherjee S, Chen LY, Papadimos TJ, Huang S, Zuraw BL, et al. (2009) Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J Biol Chem 284: 29391-29398.
10. Kang CM, Jang AS, Ahn MH, Shin JA, Kim JH, et al. (2005) Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 33: 290-296.
11. Hu-Li J, Pannetier C, Guo L, Lohning M, Gu H, et al. (2001) Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. Immunity 14: 1-11.
12. Bonder CS, Finlay-Jones JJ, Hart PH, (1999) Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain. Immunology 96: 529-536.
13. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
14. Kuroda E, Ho V, Ruschmann J, Antignano F, Hamilton M, et al. (2009) SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J Immunol 183: 3652-3660.
15. La Flamme AC, K Canagasabey, M Harvie, B. T Bäckström, (2004) Schistosomiasis protects against multiple sclerosis. Mem Inst Oswaldo Cruz 99: 33-36.
16. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, et al. (2007) Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13: 935-943.
17. Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, et al. (2004) Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J Immunol 172: 7144-7153.
18. Aharoni R, Meshorer A, Sela M, Arnon R, (2002) Oral treatment of mice with copolymer 1 (glatiramer acetate) results in the accumulation of specific Th2 cells in the central nervous system. J Neuroimmunol 126: 58-68.
19. Ponomarev ED, Maresz K, Tan Y, Dittel BN, (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721.
20. Grzych JM, Pearce E, Cheever A, Caulada ZA, Caspar P, et al. (1991) Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol 146: 1322-1327.
21. Crume KP, Miller JH, La Flamme AC, (2007) Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages. Exp Biol Med 232: 607-613.
22. Boros DL, Warren KS, (1970) Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 132: 488-507.